The Media and I: Viral Disease

Related articles

The Media and I: Measles
The Media and I: Medical Advances
The Media and I: Eye Surgery at the VA
Viral Diseases: What You Need To Know
The Media and I: Drug Approval Reciprocity
By Henry I. Miller, MS, MD — May 9, 2024

Lars Larson and I discussed on his program the distinction between eradicating and controlling viruses and the complexities of virus management posed by different viral characteristics.

Image by Michi S from Pixabay

We began by exploring the difference between eradicating and controlling viruses. I described the importance of understanding viral behavior in public health strategies – for example, their varying incubation periods and evolutionary strategies and the implications for immunity and vaccination. The conversation touched on the challenges of vaccinating against viruses with short incubation periods like COVID-19.

You can find our entire conversation here.

For those wishing to explore further,

Viral Diseases: What You Need To Know

Tags: 
COVID
SARS-CoV-2
vaccines
viruses
eradication
control of outbreaks
virus incubation time

By Henry I. Miller, MS, MD

Henry I. Miller, MS, MD, is the Glenn Swogger Distinguished Fellow at the American Council on Science and Health. His research focuses on public policy toward science, technology, and medicine, encompassing a number of areas, including pharmaceutical development, genetic engineering, models for regulatory reform, precision medicine, and the emergence of new viral diseases. Dr. Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts, including as the founding director of the Office of Biotechnology.

Latest from Henry I. Miller, MS, MD:

The Media and I: 'Global Shading' to Mitigate Climate Change
We Urgently Need More Organs for Transplantation. Science and Policy Can Come to the Rescue.
The Media and I: Viral Disease
In the Escalating Arms Race Between Viruses and Humans, New COVID Vaccines Are Critical
The Media and I: 'Oppenheimer'
More